SS Innovations International Inc. (NASDAQ: SSII), a developer of innovative surgical robotic technologies, will bring its SSi Mantra surgical robotic system to one of the largest annual gatherings of robotic surgery specialists, highlighting the company’s expanding clinical experience and growing focus on remote surgical capabilities. The company announced that the SSi Mantra will be showcased during the Society of Robotic Surgery (“SRS”) 2026 Annual Meeting, scheduled for July 23-26 in Hollywood, Florida (https://ibn.fm/FkgsY).
The robotic platform will be demonstrated throughout the conference and featured in multiple technical sessions. One of the event’s focal points will be a live robotic telesurgery in which a partial nephrectomy will be performed remotely from India, demonstrating the remote capabilities of the SSi Mantra platform. Chairman and CEO Dr. Sudhir Srivastava will participate in multiple conference presentations covering telesurgery, robotic surgery adoption and regulatory developments.
As of July 6, 2026, more than 12,375 procedures have been completed using the SSi Mantra system, including cardiac, pediatric and telesurgical procedures. Approximately 2,100 physicians have already been trained on the platform, which has been used across more than 170 different surgical procedures. This growing clinical footprint underscores the system’s versatility and the company’s commitment to expanding access to robotic surgery worldwide.
The SRS 2026 meeting provides a significant platform for SS Innovations to demonstrate its technology to leading surgeons and healthcare professionals. The live telesurgery broadcast is particularly noteworthy as it showcases the potential for remote surgical expertise to bridge geographic gaps, enabling specialists to perform complex procedures in underserved regions. This aligns with broader trends in healthcare towards telemedicine and remote care.
Dr. Sudhir Srivastava’s participation in conference presentations signals the company’s strategic focus on thought leadership and regulatory engagement. By discussing telesurgery, adoption challenges, and regulatory pathways, SS Innovations aims to position the SSi Mantra as a key player in the evolving landscape of robotic surgery.
The company’s newsroom (https://ibn.fm/SSII) provides the latest updates and information for investors and stakeholders. With over 12,000 procedures and a growing base of trained physicians, SS Innovations is demonstrating tangible progress in its mission to make robotic surgery more accessible. The SRS 2026 event represents an opportunity to accelerate adoption and solidify its presence in the global market.
